Tanika Kelly, PhD, MPH, discusses her study finding that greater chronic kidney disease (CKD) severity significantly increases the risk of cognitive impairment, with important implications for how pharmacists counsel and support these patients.
Tanika N. Kelly, PhD, MPH
Advertisement
Articles by Tanika N. Kelly, PhD, MPH
Advertisement
Latest Updated Articles
Q&A: How Severe CKD Can Cause Cognitive ImpairmentMarch 4th 2026
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
2
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
3
Anticoagulation in AFib: Risk Stratification, Therapy Selection, and Factor XI Inhibitors
4
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant Treatment of High-Risk Clear Cell RCC
5